Bio Saga Blog - A Chronicle of Life Sciences & Informatics

https://www.linkedin.com/feed/update/urn:li:activity:6282881543019036672 h ttps://www.linkedin.com/feed/update/urn:li:activity:6282881543019036672 We are HIRING !!  Do visit us at the corporate offices in Bangalore, for a dialogue with our HR specialist !!   Map Location: http://bit.ly/2tnDd50

Merck KGaA today announced that it will acquire Sigma-Aldrich for $17 billion. Under the terms of the agreement, Merck will acquire all outstanding shares of Sigma-Aldrich for $140 per share, which would represent a 37 percent premium to Sigma-Aldrich's closing stock price of $102.37 on Sept. 19. The deal is anticipated to be immediately accretive to Merck's EPS pre and EBITDA margin, the companies said, and Merck anticipates achieving annual synergies of about €260 million ($334 million) within three years after the completion of the acquisition. In a statement, Merck KGaA Chairman Karl-Ludwig Kley called the deal a "quantum leap" for the company's life science business, whose contributions to the German firm's overall earnings would more than double with the addition of Sigma-Aldrich. "In one of the world's key industries two companies that fit perfectly together have found each other to present a much broader product offering to our global cus...

Roche said today that it will acquire Genia Technologies for $125 million in cash and up to $225 million in additional payments tied to milestones. Once the deal closes, Genia will be integrated into the Roche Sequencing Unit. Genia, based in Mountain View, Calif., has been developing a single-molecule sequencing-by-synthesis technology that uses nanopore-based electrical detection and employs a semiconductor integrated circuit. Last fall, Genia and its academic collaborators at Columbia University, Harvard University, and the National Institute of Standards and Technology published proof of concept for their NanoTag sequencing technology. According to Roche, Genia's technology "is expected to reduce the price of sequencing while increasing speed and sensitivity." Roche has also been working with Pacific Biosciences on developing a sequencing system and assays for clinical diagnostics using PacBio's single-molecule real-time sequencing technology. Last fall,...

Dako is one of the leading global providers of cancer diagnostics tools. --Acquisition will strategically complement Agilent's research technologies and will accelerate growth in rapidly expanding segments of diagnostic markets. --Significantly increases base of recurring revenues. --All-cash deal is largest in Agilent's history. Expected to be immediately accretive to Agilent earnings on a non-GAAP basis. Agilent Technologies Inc. and EQT, the Sweden-based private equity group, today announced the execution of a definitive agreement for Agilent to acquire Dako, the Denmark-based cancer diagnostic company. The $2.2 billion acquisition (on a debt-free basis) is the largest in Agilent's history. Dako's products are sold in more than 100 countries, and in 2010 its annual revenue was approximately $340 million (USD). The company employs more than 1,000 people, primarily in Denmark, in Carpinteria, Calif., and other parts of the world. The acquisition is...

Dhathri Ayurveda Private Ltd houses branded consumer goods like Dhathri Hair care herbal oil, Dhathri fairness facepack, Dheedhi Shampoo etc and has evolved into an household name in the Ayurveda segment in a short span of 6 years. Dhathri, with its range of 25 ayurveda products and has won the trust of millions across the world. The products are prepared under stringent quality control and the ingredients sourced from traditional herbal gardens and untouched mountain range Post :  R and D Scientist No of opening :  3 Experience :  0 to 5 years Job Description : Following are the Openings with Dhathri Group for its R&D Department. Research Associate - Stability Study - (1 Year Experience in Stability Analysis) Pharmacology  - (2Years related Experience in Ayurveda Field) Jr.Scientist  - Food & Drug Formaulation - (3Years Expereince in Capsule,Tablet,oinment and Food Formulation) Educational Qualification :  M.Sc  - Bio-Chemistry,...

Avesthagen- a life science company in Bangalore has an opening for Drug Safety Associate.  Details:     - Experience : 0 to 3 yrs    - Job description : Database programmer will develop complex edit    checks based on study requirements & Programming of complex edit checks,    including cross-form edit checks, in order to identify discrepancies in the    data recorded on CRFs and on eCRFs     - Salary : Best in the Industry    - Education : M.Sc - Biology, M.Tech - Bio-Chemistry/Bio-Technology, Biomedical Science  Send your CV to: crtraining@avesthagen.com, yasmin@avesthagen.com  Deadline : 22.04.12 

Courtesy Bioclues Virchow Biotech Private Limited (VBPL), an innovative biotechnology company headquartered at Hyderabad, India. VBPL also has offices located in the United States of America ( at Nashville, Tennessee) With an aim of establishing itself in the sunrise industry of biotechnology, Virchow Biotech (P) Ltd commenced its Indian operations in the year 2001. The focus was to develop and manufacture a wide range of unique biologicals and high value bio-generic products at an affordable price. Since then we made impressive strides in terms of product development and have built a strong foundation with a commitment to innovation and process efficiencies. We have rapidly cornered a name for ourselves as a developer of cutting edge therapies in this rapidly evolving biotechnology space. Post :  Executives No of Opening :  Seven Experience  : 1 to 3 yrs Job Desciption :  Candidate must have good knowledge in handling HPLC analytical instrument and water an...

Dr. Reddy's, recognized consistently amongst the top pharma companies in Asia. Post :  Executive Production No of Post :  15 Experience :  2 to 6 yrs Job Description : 1.Should be able to understand equipment / capacities and schedule manufacturing. 2.Coordinating with delivery planners for mart requirement and materials availability. 3.Ensure smooth functioning and timely delivery as per commitment given 4.Close monitoring of flow to reduce lead times, inventories and improve up times of equipments Education :  PG - Biology, Life Science Location :  Hyderabad Contact Details : Executive Name:Murthy Contact Company:Dr Reddys Laboratories Ltd Address: 8-2-337, Road No 3, Banjara Hills HYDERABAD,Andhra Pradesh,India 500034 Email Address :  murthyvvnrc@drreddys.com Reference Id:Production Planning Deadline : 29.03.12

Opportunity for Freshers as Medical Editor post at Cactus Communications, Mumbai Cactus Communications is a pioneering language services company serving more than 25,000 clients across 73 countries. In line with its mission—growth through effective communication, Cactus offers specialist academic editing, medical communications, publication support, transcription, and training services to individuals and corporations across sectors such as academia, publishing, and pharmaceuticals.  Candidates with scientific field degree apply for Specialist – CSD Job at Novartis A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes us one of the most rewarding employers in our field. Designation : Specialist – CSD Job Description Freshers jobs at Jubilant LifeSciences – Biotech/ Biochem/ Microbiology Jubilant Biosys Ltd, ...

Gujarat State Biotechnology Mission (GSBTM), Gujarat Venture Finance Limited (GVFL) & Foundation for MSME Clusters (FMC) along with SkyQuest Technology Consulting Pvt. Ltd. (Knowledge Partner) PRESENTS BIOTECHNOPRENEUR TM  CAMPS 2012 Life Sciences | Medical Devices | Biotechnology | Pharmaceuticals Fostering Technology based Entrepreneurship in Gujarat The journey of Biopreneur Camps 2011 from Surat, Vallabh Vidyanagar, Baroda and Ahmedabad saw 100 participants at each venue; graced by the presence of eminent guests including Mr. Ketan Patel, MD, Troikaa Pharmaceuticals, Dr. Chandan Chatterjee, Director, The Centre for Entrepreneurship Development (CED), Govt. of Gujarat; Dr. Ravi Dhar, Senior Consultant – Biotechnology Industry Research Assistance Programme (BIRAP) of Dept. of Biotechnology, Govt. of India, Dr. V. S. Patel, Ex-Vice Chancellor, S. P. University and Director, Sophisticated Instrumentation Centre for Applied Research and Testing (SICART) and many more in additio...

PerkinElmer reported after the close of the market on Thursday that revenues in the third quarter rose 8 percent year over year, but it missed analyst estimates on the top line. Total revenues in the quarter ended Oct. 2 rose to $453.7 million, compared to $419.1 million a year ago but fell short of Wall Street estimates of $469.6 million. On an organic basis, revenues were up 4 percent year over year. The firm has made a number of purchases throughout 2011 and in the quarter those acquisitions contributed more than $20 million to the top line, CFO Frank Wilson said on a conference call after the release of the company's earnings results. The Human Health segment grew revenues to $207.4 million, up 7 percent from $194.5 million a year ago, while Environmental Health climbed to $246.3 million, a 10 percent increase from $224.6 million a year ago. On the conference call, Chairman and CEO Robert Friel said that during the quarter, growth was seen across all major geographies and most ...

PerkinElmer, Inc. , a global leader focused on improving the health and safety of people and the environment, today announced that it has signed a definitive agreement to acquire  Caliper Life Sciences, Inc. , a  Hopkinton, Massachusetts -based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets, for  $10.50  per share, for a total net purchase price of approximately  $600 million  in cash. Robert F. Friel , chairman and chief executive officer,  PerkinElmer , said, "The acquisition of  Caliper Life Sciences  brings innovative molecular imaging and detection technologies to our portfolio, complementing our world-leading offerings in life science, diagnostics, environmental and food markets." Friel added, "The R&D, application expertise, and intellectual property of the combined organization will provide our customers with enhanced knowledge and services and a strong pipeline of in...

Persistent Systems Ltd (PSL) has signed an agreement to acquire Agilent Technologies' software marketing and development business unit based in Grenoble, France. The acquisition is expected to be final by August 1, after which the unit will be called Persistent Systems, France. Dr Anand Deshpande, Chairman and Managing Director, PSL said the acquisition will contribute to Persistent's thrust in the life sciences and healthcare markets and also give it a presence in Europe. Around 30 domain experts from Agilent will come on board once the transaction is completed and more may be added, he said. The Agilent business is now focused on supplying data acquisition and control software for scientific instruments to the life sciences, environmental, energy, applied research and other markets. Currently, PSL's Life Sciences business contributes 10-12 per cent to its topline and was worth $20 million in FY 2011. The team here includes over 40 domain experts and more than 500 softw...

There is a technology roadshow organized by SkyQuest Technology Consulting (www.skyquestt.com) across some cities in India which will be a common platform for innovators and entrepreneurs of biotech/lifescience sector.  The whole idea, is to promote technology transfers and licensing of technologies through an IP marketplace.  At this event, around 50 technologies will be showcased in the form of presentations, prototypes, technology briefings and interactive sessions.  The buyers, representing nearly 50 Industry players across India are expected to discover novel potential technologies. The roadshows will spearhead the best IP marketplace at four different destinations across India in the month of March 2011.  15th - Vishakhapatnam | 17th - Hyderabad| 19th – Ahmedabad | 22nd - Vadodara  

The stats helper monkeys at WordPress.com mulled over how Bio Saga Blog did in 2010, and here’s a high level summary of its overall blog health: The  Blog-Health-o-Meter™  reads Fresher than ever. Crunchy numbers A helper monkey made this abstract painting, inspired by your stats. A Boeing 747-400 passenger jet can hold 416 passengers. This blog was viewed about  3,000  times in 2010. That’s about 7 full 747s. In 2010, there were  150  new posts, growing the total archive of this blog to 758 posts. The busiest day of the year was June 8th with 41  views. The most popular post that day was  Computational Biologist @ Pfizer UK . Where did they come from? The top referring sites in 2010 were  google.co.in ,  en.wordpress.com , emperan.com ,  obama-scandal-exposed.co.cc , and en.search.wordpress.com . Some visitors came searching, mostly for  list of pharma companies in noida ,  bioinformatics tools and softwares , ...